Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake P Mann

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Hepatology Communications|April 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsChristian A Hudert, Leon A Adams, Anna Alisi, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2026
ESPGHAN position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver diseaseJake P Mann, Sander Lefere, Maarten Buytaert, et al.
Journal of Hepatology|September 4, 2020
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysisKevin Teo, Kushala W M Abeysekera, Leon Adams, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Hepatology Communications|April 12, 2022
Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanismsChristian A Hudert, Leon A Adams, Anna Alisi, et al.
Journal of Hepatology|August 27, 2023
Uniting to defeat steatotic liver disease: A global mission to promote healthy livers and healthy livesAleksander Krag, Maria Buti, Jeffrey V Lazarus, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 30, 2026
ESPGHAN position paper on screening, diagnosis and investigation of paediatric metabolic dysfunction-associated steatotic liver diseaseJake P Mann, Sander Lefere, Maarten Buytaert, et al.
Journal of Hepatology|September 4, 2020
rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysisKevin Teo, Kushala W M Abeysekera, Leon Adams, et al.
Pageof 5